Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.91 USD | +0.88% |
|
-28.76% | -55.39% |
20/06 | Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies | CI |
07/05 | Transcript : Cryoport, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.39% | 340M | |
-14.31% | 6.56B | |
+61.83% | 6.71B | |
+2.81% | 3.55B | |
+18.95% | 2.32B | |
+5.06% | 962M | |
-9.03% | 617M | |
-10.06% | 444M | |
-41.79% | 417M | |
+3.75% | 332M |
- Stock Market
- Equities
- CYRX Stock
- News Cryoport, Inc.
- Needham Adjusts Price Target on Cryoport to $21 From $30, Keeps Buy Rating